A. Ochsenbein

Type de document

Articles (6)

Co-auteur

Date

Source

Mot-clé

Patients (5) Patients (5) survie (4) Survival (4) Treatment (3) Human beings (3) Expression (3) Size (3) thérapie (2) effet (2) maladie (2) âge (2) taux (2) Diagnosis (2) Cases (2) Acute myeloid leukemia (2) Therapeutics (2) Theater (2) Swiss (2) Prognosis (2) Performance (2) Lymphocytes (2) Lungs--Cancer (2) Lungs (2) Impact (2) Drama (2) Diagnosis (2) Cells (2) Cancer (2) Age (2)

Documents écrit par A. Ochsenbein (6) | parle de A. Ochsenbein (0)

The effect of neoadjuvant therapy on PD-L1 expression and CD8+lymphocyte density in non-small cell lung cancer.
P. Zens et al.
A prognostic score for non-small cell lung cancer resected after neoadjuvant therapy in comparison with the tumor-node-metastases classification and major pathological response.
P. Zens et al.
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML.
B. Salomé et al. (26 nov. 2019)
CD127+ innate lymphoid cells are dysregulated in treatment naïve acute myeloid leukemia patients at diagnosis.
S. Trabanelli et al. (2015)
TREM-1 deficiency can attenuate disease severity without affecting pathogen clearance.
B. Weber et al. (2014)
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07).
R. von Moos et al. (2012)